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ABSTRACT
Background: Colorectal cancer is the fourth leading cause of cancer-related mortality worldwide. Early 
detection of colorectal cancer is necessary in term of increasing survival. Immunochemical fecal occult blood 
test (I-FOBT) is one of the simple and inexpensive screening modality that can be used widely. No data has 
been available yet regarding the usage of I-FOBT in Indonesia. This study is a prevalence study of I-FOBT in 
asymptomatic population in Indonesia. 
Method: A cross sectional study was conducted in asymptomatic population visiting five public health service 
centers in Depok district, West Java, Indonesia. This study was performed from January to March 2012. Case 
report form and I-FOBT kit were used to assess and screen the patients. Statistic analysis was performed using 
Chi-square test.
Results: The prevalence of positive I-FOBT was almost equally distributed among age group. Female 
dominated whole patients 202 (72.7%). Most of them had middle to low education level 116 (41.7%). As many 
as 50.7% patients had normal body mass index. We had 11 (4%) patients with positive result of I-FOBT. 
Conclusion: Prevalence of positive result of I-FOBT in asymptomatic population in Indonesia was 4%. 
Further studies were needed to confirm sensitivity and specifity of I-FOBT in Indonesia. 
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ABSTRAK
Latar belakang: Kanker kolorektal merupakan penyebab keempat terbanyak kematian akibat kanker di dunia. 
Deteksi dini kanker kolorektal diperlukan untuk meningkatkan kesintasan. Immunochemical fecal occult blood 
test (I-FOBT) adalah modalitas uji penapisan sederhana dan murah yang dapat digunakan secara luas. Belum 
terdapat data mengenai pemanfaatan I-FOBT di Indonesia. Penelitian ini ditujukan untuk melihat prevalensi 
hasil I-FOBT pada populasi tanpa gejala di Indonesia.
Metode: Penelitian potong lintang telah dilakukan pada populasi tanpa gejala yang mengunjungi lima fasilitas 
pelayanan kesehatan masyarakat di beberapa kecamatan wilayah Depok, Jawa Barat, Indonesia. Penelitian ini 
dilakukan pada bulan Januari hingga Maret 2012. Formulir laporan kasus dan kit I-FOBT digunakan untuk 
menilai dan menapis subjek penelitian. Analisis statistik dilakukan dengan menggunakai uji Chi-square.
Hasil: Prevalensi I-FOBT positif yang didapat hampir terdistribusi berimbang di setiap kelompok usia. Wanita 
mendominasi jumlah pasien penelitian 202 (72,7%). Pasien kebanyakan berpendidikan rendah 116 (41,7%). 
Sebanyak 50,7% pasien memiliki indeks massa tubuh yang normal. Terdapat 11 (4%) pasien yang memberikan 
hasil uji I-FOBT positif. 
Simpulan: Prevalensi uji I-FOBT positif pada populasi tanpa gejala di Indonesia adalah 4%. Penelitian 
lanjutan diperlukan untuk menilai sensitivitas dan spesifisitas uji I-FOBT di Indonesia.
Kata kunci: kanker kolorektal, immunochemical fecal occult blood test (I-FOBT), deteksi dini
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INTRODUCTION
Colorectal cancer (CRC) is the fourth most common 
malignancy in the world and is considered as a serious 
medical problem.1 Data from Globocan 2008 shows 
that the 5-year prevalence of CRC is the second highest 
after breast cancer and 609,051 people per year died 
as a result of the cancer.1 The mortality rate of CRC 
from 1985 to 2005 was decreased in several countries.2 
This decrease were due to screening and/or better 
treatment.2–5 However, increases in mortality rates 
are still occurring in countries that may have limited 
resources, including Mexico and Brazil in South 
America and Romania and Russia in Eastern Europe, 
compared with longstanding, economically developed 
countries.2 International practical guidelines and expert 
consensus recommend colorectal cancer screening in 
individuals older than 50 years old.6 If the cancer were 
found in the early stage, localized and found in the 
early stage, study shows that the 5-year survival rate 
of this cancer may reach up to 95%.7
The fecal occult blood test (FOBT) has been 
recommended as screening method of colorectal 
cancer.8,9 There are two types of test to identify 
colorectal cancer at early stage: Guaiac FOBT 
(G-FOBT) and immunochemical FOBT (I-FOBT). 
However, screening of colorectal cancer using G-FOBT 
has many disadvantages compared to I-FOBT. The 
G-FOBT has high false positive value because of the 
inability to differentiate the source of occult blood 
along gastrointestinal tract. The G-FOBT also interacts 
with several foods that create false positive result and 
three days diet restriction is needed before conducting 
G-FOBT. Examining patient using I-FOBT does not 
require diet restriction and more specific in detecting 
bleeding in the colon and rectum. Hence, the usage of 
I-FOBT is easier and more comfortable for the patients 
as it requires only single stool sample. Overall, I-FOBT 
has better sensitivity and specificity than G-FOBT.10
The I-FOBT is considered a novel method for 
screening of colorectal carcinoma in Indonesia. This 
method has never been used widely as screening 
method for early detection of CRC in Indonesia. 
In limited resources country as Indonesia, simple 
and affordable test for early detection of colorectal 
carcinoma is a very important element. For supporting 
the use of this test in general population in Indonesia, 
it is important to do a population-based study on 
asymptomatic population using I-FOBT in the rural 
setting.
METHOD
This is a population based survey conducted in five 
community health centers in Depok district, West Java. 
It was conducted from January 2012 to February 2012. 
The target population of this study were those who live 
in the proximity of the five largest community health 
centres in Depok. These five community health centres 
were Beji, Cimanggis, Cipayung, Pancoran Mas and 
Sukmajaya.
Using cluster consecutive sampling, all patients 
visited Depok community health centre were included. 
The inclusion criteria were as follows; patient lived 
in Depok, aged older than 40 years old and agreed 
to sign the informed consent. The exclusion criteria 
were patient with obvious gastrointestinal bleeding, 
history of colorectal cancer and patient with very soft 
stool. Patient with obvious gastrointestinal bleeding 
does not need FOBT, while patient with previous 
history of colorectal cancer does not need screening, 
but surveillance. Additionally very soft stool may alter 
I-FOBT result.
The prediction for sample size was calculated 
using the population estimation formula with absolute 
precision, with p = 0.232. The result of this sample size 
calculation were 212. The feces was examined using 
I-FOBT method. Those with positive I-FOBT would 
further undergo colonoscopy examination.
Data analysis were done using SPSS 17.0. 
Validation processes were done to ensure the integrity 
of recorded data. Categorical descriptive data was 
shown in percentage. Numerical and continuous data 
were shown in the form of average with standard 
deviation if the distribution was normal, or in the 
form of median with minimal and maximal value 
if the distribution was not normal. Descriptive and 
analytical data were given in narrative tabular and 
graphical forms. 
RESULTS
All 278 patients from five community health 
centres at Depok had been collected from January to 
February 2012. The demographic data were collected 
and their stool sample were examined for I-FOBT. The 
distribution of study patients was as follows:
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Figure 1. Distribution of patients (n) from five district level 
community health centres in Depok
From Figure 1 we can see the distribution of the 
patient throughout the five community health centres 
was not well distributed. This might be caused by 
patient`s rejection to participate in this study. The 
reasons varied, including uncomfortable with the study 
process in which they had to collect stool sample inside 
a tube, anxious of positive I-FOBT result, busy at work 
and difficulty in returning the stool sample.
From this study, we found that the prevalence was 
almost equally distributed among age group, with female 
dominated (72.7%). The majority of study subjects had 
primary and secondary school as their last education 
(41.7%). Almost all of them were married (93.2%) and 
the occupation of the study participant were mainly 
housewife (45.3%). Almost half the patient (50.7%) had 
normal body mass index (BMI).
Table 1. Basic characteristics distribution of study patients
Variable Totaln (%)
Age group (year)
40-49 
50-59 
> 60
Sex
Male
Female
Education level
Uneducated
Primary and secondary school
High school
University/college
Marital status
Married
Not married
Divorced-deceased
Divorced
Employment
Full-time
Part-time
Housewife
Unemployed
Other
Monthly earning (IDR)
< 500,000
500,000-1,000,000
1,000,000-5,000,000
> 5,000,000
No answer
Body mass index (kg/m2)
Thin (≤ 18.49)
Normal (18.50-24.99)
Overweight (25.00-25.99) 
Obese (≥ 30.00)
102
90 
86 
76 
202 
14 
116 
93 
5 
259 
4 
13 
2 
64 
15 
126 
37 
36 
70 
54 
108 
9 
37 
37 
141 
80 
20 
(36.7%)
(32.3%)
(31%)
(27.3%)
(72.7%)
(5%)
(41.7%)
(33.5%)
(19.8%)
(93.2%)
(1.4%)
(4.7%)
(0.7%)
(23%)
(5.4%)
(45.3%)
(13.3%)
(13%)
(25.2%)
(19.4%)
(38.9%)
(3.2%)
(13.3%)
(13.3%)
(50.7%)
(28.8%)
(7.2%)
Table 2. Distribution of patient history
Variable Yesn (%)
No
n (%)
History of malignancy
Family history of malignancy 
Medical history
Diabetes mellitus
Hypertension
Coronary heart disease 
Hematoschezia 
Diarrhea/constipation
Anemia 
Mucoid stool
Stomach/anal pain
Weight loss
Altered bowel habit
Vomiting
Malaise/fatigue 
8 (2.9%)
35 (12.6%)
42 (15.1%)
109 39.2%)
23 (8.3%)
34 (12.2%)
81 (29.1%)
24 (8.6%)
33 (11.9%)
69 (24.8%)
23 (8.3%)
30 (10.8%)
24 (8.6%)
75 (27%)
270 (97.1%)
240 (86.3%)
236 (84.9%)
169 (60.8%)
255 (91.7%)
246 (88.4%)
197 (70.9%)
254 (91.4%)
245 (88.1%)
209 (74.1%)
255 (91.7%)
248 (89.2%)
254 (91.3%)
203 (73%)
Table 3. Distribution of patients' charateristic with I-FOBT result
Variable
I-FOBT Result
Positive
n (%)
Negative
n (%)
Age group (years)
40-49
50-59 
> 60
Sex
Male
Female
Education level
Uneducated
Primary and secondary school
High school
University/college
Marital status
Married
Not married 
Divorced-deceased
Divorced
Employment
Full-time
Part-time 
Housewife
Unemployed
Other
Monthly earning (IDR)
< 500,000
500,000-1,000,000
1,000,000-5,000,000
> 5,000,000
No answer
Body mass index (kg/m2)
Thin (≤ 18.49)
Normal (18.50-24.99)
Overweight (25.00-25.99) 
Obese (≥ 30.00)
2 (2%)
5 (5.7%)
4 (4.7%)
4 (5.3%)
7 (3.5%)
0 (0%)
5 (4.3%)
5 (5.4%)
1 (1.8%)
11 (4.2%)
0 (0%)
0 (0%)
0 (0%)
 2 (3.1%)
 0 (0%)
 5 (4%)
 2 (5.4%)
 2 (5.6%)
5 (7.1%)
 2 (3.7%)
 2 (1.9%)
 0 (0%)
 2 (6.9%)
 2 (5.4%)
 8 (5.7%)
 1 (1.3%)
 0 (0%)
99 (98%)
83(94.3%)
82 (95.3%)
72 (94.7%)
195 (96.5%)
14 (100%)
111(95.7%)
88 (94.6%)
54 (98.2%)
248 (95.8%)
4 (100%)
13 (100%)
2 (100%)
 62 (96.9%)
 15 (100%)
 121 (96%)
 35 (94.6%)
 34 (94.4%)
65 (92.9%)
52 (96.3%)
106 (98.1%)
9 (100%)
27 (93.1%)
 35 (94.6%)
 133(94.3%)
 79 (98.8%)
 20 (100%)
I-FOBT: immunochemical fecal occult blood test
Eleven asymptomatic patients were found to have 
positive I-FOBT result (prevalence of 4%), as shown 
in Figure 2.
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DISCUSSION
The age group was equally distributed among 
patients. Most patients were female (72.7%). Statistics 
showed 142,672 American diagnosed with colorectal 
cancer, among 69.917 of them were female.11 It may be 
caused by higher health consciousness among female 
patients. Almost half of the female study patients 
were housewives, and this gave them more free time 
compared to men, so they had more time to go to the 
health centre.
Large proportion of the patients had primary and 
secondary school as their education level (41.7%). 
The education level influenced the health literacy, the 
amount of information understood by patients and the 
comprehension of information given. In low education 
level patients, we need to give simpler language when 
giving explanation about colorectal cancer prevention 
information and this would lead to higher rate of 
adherence.
Almost half of the patients had normal BMI (50.7%). 
Higher BMI will lead to two times fold increasing of 
colon cancer risk. Lack of physical activity and central 
obesity were also related to incidence of colon cancer. 
Moderate to vigorous physical activity will decrease 
incidence of colon cancer by 4 to 50%.
This study showed interesting findings of previous 
malignancy history. Eight patients reported positive 
previous malignancy history, which were cervical 
cancer, skin cancer, post-hysterectomy uterine 
fibroid, prostate tumor, sof tissue tumor, lymph node 
malignancy and breast tumor. The incidence ranged 
from 1963 to 2009. Thirty five patients had positive 
family history of malignancy. Beside those factors 
mentioned above, family history also plays role in 
incidence of colorectal cancer.
Eleven asymptomatic patients were found to have 
positive I-FOBT result (prevalence of 4%). In the 
previous study, the sensitivity and specificity of fecal 
immunochemical test (FIT) in CRC screening in 
Indonesia using OC Light® and Oncoprobe® kit were 
39.5% vs. 42.1% and 86.4% vs. 81.8% respectively.12 
Those patients with positive I-FOBT were referred 
for further work-up tests but they did not comply and 
participate further in the study.
This study is the first epidemiological based study 
in the topic of early detection of colorectal cancer 
using I-FOBT. I-FOBT is considered to be new, 
relatively cheap and easy to perform. The importance 
of colorectal cancer screening is that early lesion 
found can increase survival chance of the patient. 
Unfortunately, colonoscopy evaluation among the 
positive patients has not been performed in respect to 
patients' preferences. 
CONCLUSION
The prevalence of positive value of I-FOBT in the 
asymptomatic population is 4%. Further study should 
be done to confirm I-FOBT finding with colonoscopy 
and histopathological test.
REFERENCES
1. GLOBOCAN 2008. Country Fast Stat [cited 2013 Sept 
5]. Available from: URL: http://globocan.iarc.fr/factsheet.
asp#BOTH
2. Center MM, Jemal A, Smith RA, Ward E. Worldwide variations 
in colorectal cancer. CA Cancer J Clin 2009;59:366–78.
3. Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. 
Cochrane systematic review of colorectal cancer screening 
using the fecal occult blood test (hemoccult): an update. Am 
J Gastroenterol 2008;103:1541–9.
4. Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach 
DR, Rabeneck L. Association of colonoscopy and death from 
colorectal cancer. Ann Intern Med 2009;150:1–8.
5. Walsh JME, Terdiman JP. Colorectal cancer screening: 
scientific review. JAMA 2003;289:1288–96.
6. Kronborg O, Fenger C, Olsen J, Jørgensen OD, Søndergaard 
O. Randomised study of screening for colorectal cancer with 
faecal-occult-blood test. Lancet 1996;348:1467–71.
7. Pezzoli A, Matarese V, Rubini M, Simoni M, Caravelli GC, 
Stockbrugger R, et al. Colorectal cancer screening: results of 
a 5-year program in asymptomatic subjects at increased risk. 
Dig Liver Dis 2007;39:33–9.
8. Levin B, Lieberman DA, McFarland B, Andrews KS, Brooks 
D, Bond J, et al. Screening and surveillance for the early 
detection of colorectal cancer and adenomatous polyps, 
2008: a joint guideline from the American Cancer Society, 
the US Multi-Society Task Force on Colorectal Cancer, 
and the American College of Radiology. Gastroenterology 
2008;134:1570–95.
Figure 2. I-FOBT results in asymptomatic patients
200
250
150
100
50
0
300
267
I-
F
O
B
T
 r
e
s
u
lt
Frequency
Posive Nega ve
Volume 15, Number 1, April 2014 19
The Use of Immunochemical Fecal Occult Blood Test as Colorectal Cancer Screening Tool in Asymptomatic Population in Indonesia
9. Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke 
CA, Inadomi JM. American College of Gastroenterology 
guidelines for colorectal cancer screening 2009 [corrected]. 
Am J Gastroenterol 2009;104:739–50.
10. Li S, Wang H, Hu J, Li N, Liu Y, Wu Z, et al. New 
immunochemical fecal occult blood test with two-consecutive 
stool sample testing is a cost-effective approach for colon 
cancer screening: results of a prospective multicenter study 
in Chinese patients. Int J Cancer 2006;118:3078–83.
11. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. 
Cancer statistics, 2008. CA Cancer J Clin 2008;58:71–96.
12. Fauzi A, Abdullah M, Simadibrata M, Syam AF, Wijayadi 
T, Rani AA. The accuracy of fecal immunochemical test in 
early detection of colorectal cancer. Digestion 2011;83:225. 
Correspondence: 
Murdani Abdullah 
Division of Gastroenterology 
Department of Internal Medicine 
Dr. Cipto Mangunkusumo General National Hospital 
Jl. Diponegoro No. 71 Jakarta Indonesia 
Phone: +62-21-3153957 Facsimile: +62-21-3142454 
E-mail: murdani08@yahoo.com
